Cargando…
Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
Autores principales: | Tzouvelekis, Argyris, Bouros, Demosthenes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948160/ https://www.ncbi.nlm.nih.gov/pubmed/31901856 http://dx.doi.org/10.1016/j.ebiom.2019.11.052 |
Ejemplares similares
-
Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005) -
Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006) -
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012) -
Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019) -
Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)